# Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity

> **NCT06214468** · PHASE1 · COMPLETED · sponsor: **University of South Alabama** · enrollment: 26 (actual)

## Conditions studied

- Drug Toxicity

## Interventions

- **COMBINATION_PRODUCT:** Acetaminophen and Nicotinamide Riboside
- **DRUG:** Acetaminophen

## Key facts

- **NCT ID:** NCT06214468
- **Lead sponsor:** University of South Alabama
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-15
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06214468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06214468, "Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06214468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*